EUVIMEDEUVIMED entdecken
Crossref

Identification and Screening of Novel Anti-Cancer Compounds for Aurora Kinase-A from Chemical Database

Ipsa A Singh, Kiran Bharat Lokhande, K Venkateswara Swamy

Drug Research · 01.01.2023 · 73 (01) · 30-39

DOI: 10.1055/a-1877-4693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.01.2023. Verfasst von Ipsa A Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Research Laboratory, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pune, India. Hauptthemen laut MEDLINE: Aurora Kinase A, Molecular Dynamics Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aurora kinase is a group of enzymes that belongs to a serine-threonine family and plays a critical role in cellular division. Aurora Kinase A is overexpressed and distributed beyond the nucleus and is involved in tumorigenesis. Flavones are a class of flavonoids that are present in plants that show anticancer activity. Similar compounds of 2’Fluoroflavones are retrieved from the PubChem database. Then drug-like filters viz. REOS and PAINS were applied to remove toxic compounds using Canvas software, resulting in 3882 compounds being subjected to Glide docking with Aurora kinase A. The lead compounds were selected on the merit of hydrogen bonding, salt bridge, as well as pi-pi interactions, 4-(6-Fluoro-4-oxychromen-2yl) benzoic acid, has been found one of the best molecules from docking studies. The binding mode of the lead compound with AURKA reveals that the amino acid residues viz, Lys162, Ala213, and His280 are more important for binding with the binding affinity of -11.760 kcal/mol. The molecular dynamics simulations of 100 ns were done, which shows the mean RMSD value of 1.77 Å for all 3 complexes of the protein and Fluoroflavone and its analogs. This shows that Fluoroflavone and its 2 best analogs are tightly attached to the active sites and thus have conformational stability. Our finding suggests that 4-(6-fluoro-4-oxochromen-2-yl)benzoic acid and 4-(4-Oxochromen-2-yl)benzoate can be further used in vitro and in vivo experiments and can probably serve as a novel drug for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aurora Kinase AMolecular Dynamics SimulationCatalytic DomainDatabases, ChemicalBenzoic Acid

Substanzen

Aurora Kinase ABenzoic Acid

Autor:innen und Institutionen

  • Bioinformatics Research Laboratory, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pune, India.
  • Drug Discovery Group, MIT School of Bioengineering Sciences & Research, MIT Art, Design and Technology University, Pune, India.

Zitieren

APA

Singh, I. A., Lokhande, K. B., & Swamy, K. V. (2023). Identification and Screening of Novel Anti-Cancer Compounds for Aurora Kinase-A from Chemical Database. Drug Research, 73(01), 30-39. https://doi.org/10.1055/a-1877-4693

Vancouver

Singh IA, Lokhande KB, Swamy KV. Identification and Screening of Novel Anti-Cancer Compounds for Aurora Kinase-A from Chemical Database. Drug Research. 2023;73(01):30-39. doi:10.1055/a-1877-4693

BibTeX
@article{Singh2023,
  author = {Singh, Ipsa A and Lokhande, Kiran Bharat and Swamy, K Venkateswara},
  title = {Identification and Screening of Novel Anti-Cancer Compounds for Aurora Kinase-A from Chemical Database},
  journal = {Drug Research},
  year = {2023},
  volume = {73},
  number = {01},
  pages = {30--39},
  doi = {10.1055/a-1877-4693}
}
Kostenlos starten →